Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2007-07-31
2007-07-31
Campell, Bruce (Department: 1648)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S024310, C536S024320, C536S024330, C435S091200
Reexamination Certificate
active
10759514
ABSTRACT:
The present invention provides methods and compositions for determining the presence and/or amount of HCV nucleic acids in a test sample. In particular, substantially purified oligonucleotide primers and probes are described that can be used for qualitatively and quantitatively detecting HCV nucleic acid in a test sample by amplification methods. The present invention also provides primers and probes for generating and detecting control nucleic acid sequences that provide a convenient method for assessing internal quality control of the HCV assay.
REFERENCES:
patent: 4868105 (1989-09-01), Urdea et al.
patent: 5527669 (1996-06-01), Resnick et al.
patent: 5538848 (1996-07-01), Livak et al.
patent: 5635352 (1997-06-01), Urdea et al.
patent: 5681697 (1997-10-01), Urdea et al.
patent: 5691146 (1997-11-01), Mayrand
patent: 5723591 (1998-03-01), Livak et al.
patent: 5736333 (1998-04-01), Livak et al.
patent: 5837442 (1998-11-01), Tsang
patent: 5866336 (1999-02-01), Nazarenko et al.
patent: 5876930 (1999-03-01), Livak et al.
patent: 5952202 (1999-09-01), Aoyagi et al.
patent: 6028290 (2000-02-01), Yashuhara et al.
patent: 6030787 (2000-02-01), Livak et al.
patent: 6060240 (2000-05-01), Kamb et al.
patent: 6150107 (2000-11-01), Glazer et al.
patent: 6258569 (2001-07-01), Livak et al.
patent: 6297016 (2001-10-01), Egholm et al.
patent: 6316230 (2001-11-01), Egholm et al.
patent: 6316610 (2001-11-01), Lee et al.
patent: 0529493 (1997-12-01), None
patent: 103899-A/10 (1999-04-01), None
AF 059603 published on NCBI. pp. 1-2.
Beames et al., “Development of a Primary Tamarin Hepatocyte Culture System for GB Virus-B: A Surrogate Model for Hepatitis C Virus,” Journal of Virology, 74(24):11764-11772, 2000.
Bukh et al., “Sequence Analysis of the 5′ Noncoding Region of Hepatitis C Virus,” Proc. Natl. Acad. Sci. USA, 89:4942-4946, 1992.
Chu et al., “Postsynthesis Functionalization of Oligonucleotides,” Methods in Molecular Biology, 26:145-165, 1994.
Henning et al., “A Novel RT-PCR for Reliable and Rapid HCV RNA Screening of Blood Donations,” Transfusion, 41:1100-1106, 2001.
Hileman et al., “Synthesis and Characterization of Conjugates Formed Between Periodate-Oxidized Ribonucleotides and Amine-Containing Fluorophores,” Bioconjugate Chem., 5:436-444, 1994.
Kawai et al., “Quantification of Hepatitis C Virus by TaqMan PCR: Comparison with HCV Amplicor Monitor Assay,” Journal of Medical Virology, 58:121-126, 1999.
Kleiber et al., “Performance Characteristics of a Quantitative, Homogeneous TaqMan RT-PCR Test for HCV RNA,” Journal of Molecular Diagnostics, 2(3)158-166, 2000.
Komurian-Pradel et al., “Quantitation of HCV RNA Using Real-Time PCR and Fluorimetry,” Journal of Virological Methods, 95:111-119, 2001.
Landegren et al., “DNA Diagnostics-Molecular Techniques and Automation,” Science, 242:229, 1998.
Martell et al., “High-Throughput Real-Time Reverse Transcription-PCR Quantitation of Hepatitis C Virus RNA,” Journal of Clinical Microbiology, 37(2)327-332, 1999.
Matthews et al., “Analytical Strategies for the Use of DNA Probes,” Analytical Biochemistry, 169-1-25, 1988.
Meng et al., “Automated Multiplex Assay System for Simultaneous Detection of Hepatitis B Virus DNA, Hepatitis C Virus RNA, and Human Immunodeficiency Virus Type 1 RNA,” Journal of Clinical Microbiology, 2937-2945, 2001.
Mercier et al., “Simultaneous Screening for HBV DNA and HCV RNA Genomes in Blood Donations Using A Novel TaqMan PCR Assay,” Journal of Virological Methods, 77:1-9, 1999.
Theodore E. Millfin, “Use and Applications of Nucleic Acid Probes in the Clinical Laboratory,” Clinical Chemistry, 35(9):1819-1825, 1989.
Morris et al., “Rapid Reverse Transcription-PCR Detection of Hepatitis C Virus RNA in Serum by Using the TaqMan Fluorogenic Detection System,” Journal of Clinical Microbiology, 34(12):2933-2936, 1996.
Petrik et al., “High Throughput PCR Detection of HCV Based on Semiautomated Multisample RNA Capture,” Journal of Virological Methods, 64:147-159, 1997.
Randall Saiki, “Amplification of Genomic DNA,” PCR Protocols: A Guide to Methods and Applications, Academic Press, Ch. 2, p. 13-20, 1990.
Van Schie et al., “Semiautomated Clone Verification by Real-Time PCR Using Molecular Beacons,” BioTechniques, 29:1296-1308, 2000.
Wharam et al., “Specific Detection of DNA and RNA Targets Using a Novel Isothermal Nucleic Acid Amplification Assay Based on the Formation of a Three-Way Junction Structure,” Nucleic Acids Research, 29(11):1-8, 2001.
Hafner et al., “Isothermal Amplification and Multimerization of DNA byBstDNA Polymerase,” BioTechniques, 30:825-867, 2001.
Young et al., “Detection of Hepatitis C Virus RNA by a Combined Reverse Transcription-Polymerase Chain Reaction Assay,” Journal of Clinical Microbiology, 31(4):882-886, 1993.
Young et al., “Detection of Hepatitis C Virus RNA by a Combined Reverse Transcription PCR Assay: Comparison with Nested Amplification and Antibody Testing,” Journal of Clinical Microbiology, 33(3):654-657, 1995.
Baumann Russell
Hamdan Hasnah
Lewinski Michael
Campell Bruce
Foley & Lardner LLP
Li Bao Qun
Quest Diagnostics Investments Incorporated
LandOfFree
Oligonucleotides and methods for detecting hepatitis C viral... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oligonucleotides and methods for detecting hepatitis C viral..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligonucleotides and methods for detecting hepatitis C viral... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3720617